Favorable Alteration of Tumor Microenvironment by Immunomodulatory Cytokines for Efficient T-Cell Therapy in Solid Tumors

• Siri Tähtinen,

  Affiliation Cancer Gene Therapy Group, Department of Pathology and Transplantation Laboratory, Haartman Institute, University of Helsinki, Helsinki, Finland

  ⨯
• Saija Kaikkonen,

  Affiliation Cancer Gene Therapy Group, Department of Pathology and Transplantation Laboratory, Haartman Institute, University of Helsinki, Helsinki, Finland

  ⨯
• Maiju Merisalo-Soikkeli,

  Affiliation Cancer Gene Therapy Group, Department of Pathology and Transplantation Laboratory, Haartman Institute, University of Helsinki, Helsinki, Finland

  ⨯
• Susanna Grönberg-Vähä-Koskela,

  Affiliation Cancer Gene Therapy Group, Department of Pathology and Transplantation Laboratory, Haartman Institute, University of Helsinki, Helsinki, Finland

  ⨯
• Anna Kanerva,

  Affiliations Cancer Gene Therapy Group, Department of Pathology and Transplantation Laboratory, Haartman Institute, University of Helsinki, Helsinki, Finland, Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland

  ⨯
• Suvi Parviainen,

  Affiliations Cancer Gene Therapy Group, Department of Pathology and Transplantation Laboratory, Haartman Institute, University of Helsinki, Helsinki, Finland, TILT Biotherapeutics Ltd, Helsinki, Finland

  ⨯
• Markus Vähä-Koskela,

  Affiliation Cancer Gene Therapy Group, Department of Pathology and Transplantation Laboratory, Haartman Institute, University of Helsinki, Helsinki, Finland

  ⨯
• Akseli Hemminki

  * E-mail: akseli.hemminki@helsinki.fi

  Affiliations Cancer Gene Therapy Group, Department of Pathology and Transplantation Laboratory, Haartman Institute, University of Helsinki, Helsinki, Finland, TILT Biotherapeutics Ltd, Helsinki, Finland, Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland

  ⨯